Gamma

580. Utility of the combination of hederagenin glucoside saponins and chromane hydrazone in the topical treatment of canine cutaneous leishmaniasis. An observational study. Parasitology Research, 2022, 121(5):1419-1428. doi:10.1007/s00436-022-07467-x  

579. Coumaro-chalcones synthesized under solvent-free conditions as potential agents against malaria, leishmania and trypanosomiasis. Heliyon. 2022, 8(2): e08939. doi: 10.1016/j.heliyon. 2022.e08939   

578. In vitro metabolism of helenalin acetate and 11α,13-dihydrohelenalin acetate: natural sesquiterpene lactones from arnica. Metabolites. 2022, 17;12(1):88. doi:10.3390/metabo12010088   

577. Cambios en el comportamiento epidemiológico de la leishmaniasis tegumentaria americana causada por Leishmania panamensis en Colombia (1986-2018) y variaciones en el número de copias de genes asociados con virulencia. Hechos Microbiológicos, 2022. 12(2): 35-47. doi:10.17533/udea.hm.v12n2a04   

576. Dermal Absorption of Sesquiterpene Lactones from Arnica Tincture. Pharmaceutics, 2022, 14(4):742. doi: 10.3390/pharmaceutics14040742   

575. Evaluation of Pharmacokinetic and Toxicological Parameters of Arnica Tincture after Dermal Application In Vivo. Pharmaceutics, 2022, 14(11):2379. doi: 10.3390/pharmaceutics14112379 

574. Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi. Archieves der Pharmazie, 2022, 355(3): e2100432. doi: 10.1002/ardp.202100432  

573. Menthol carbonates as potent antiparasitic agents: synthesis and in vitro studies along with computer-aided approaches. BMC Complementary and Alternative Medicine, 2022, 22(1):156. doi: 10.1186/s12906-022-03636-8 

571. Therapeutic Efficacy of Arnica in Hamsters with Cutaneous Leishmaniasis Caused by Leishmania braziliensis and L. tropica. Pharmaceuticals, 2022, 15(7):776. doi: 10.3390/ph15070776  

570. In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi. Pathogens. 2022, 11(6):616. doi: 10.3390/pathogens1106061  

569. Effect of the variation in the extracellular concentration of l-arginine in the physiology of Leishmania (Viannia) braziliensis and its susceptibility to some antileishmanial drugs. Experimental Parasitology, 2022, 242:108395. doi: 10.1016/j.exppara.2022.108395  

568. Synthesis of high crystallinity biphasic calcium phosphates/gold nanoparticles composites by solution combustion method with antimicrobial response. Boletin de la Sociedad Española de Cerámica y Vidrio. 2022, 61(5):487-497   

567. Farm management practices, biosecurity and influenza a virus detection in swine farms: a comprehensive study in Colombia. Porcine Health Management. 2022, 8:42. doi: 0.1186/s40813-022-00287-6   

566. Electrochemical genosensor for the specific detection of SARS-CoV-2. Talanta, 2022, 1(245):123482. doi: 10.1016/j.talanta.2022.123482  

565. Prediction of potential cysteine synthase inhibitors of Leishmania braziliensis and Leishmania major parasites by computational screening. Acta Tropica, 2022, 225:106182. doi: 10.1016/j.actatropica.2021.106182   

564. Differential detection of zika virus based on PCR. Journal of Virology Methods. 2022, 301:114459. doi: 10.1016/j.jviromet.2022.114459  

563. Filling the gaps in Leishmania naiffi and Leishmania guyanensis genome plasticity. G3, 2022, 12(1): jkab377. doi:10.1093/g3journal/jkab377  

562. Expresión génica en células de granulosa bovinas de folículos en crecimiento. Revista MVZ Córdoba, 2022, 27(1): e2013. doi:10.21897/rmvz.2013   

561. A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World.  PLoS Negl Trop Dis. 2022, 16(3): e0010238. doi: 10.1371/journal.pntd.0010238 

560. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. Lancet Child Adolesc Health, 2022, 6(2):86-95. doi:10.1016/S2352-4642(21)00328-X  

559. In silico, In vitro, and pharmacokinetic studies of UBMC-4, a potential novel compound for treating against Trypanosoma cruzi. Pathogens. 2022, 11(6):616. doi: 10.3390/pathogens11060616 

558. Prediction of potential cysteine synthase inhibitors of Leishmania braziliensis and Leishmania major parasites by computational screening? Acta Tropica, 2022, 225:106182. doi: 10.1016/j.actatropica.2021.106182